目前儿童耐药结核病的治疗方法
H Simon Schaaf1, Jennifer Hughes2
1Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. hss@sun.ac.za.
对患有耐药结核病 (RR/MDR-TB) 的儿童进行最佳诊断和管理需要识别成人病例和查接触者. 个性化,全口服治疗方案改善了结果,强调护理人员的支持和监测,以获得更好的结果.
科学领域:
- 儿童传染病 儿童传染病
- 菌根菌感染 菌根菌感染
- 全球卫生健康 全球卫生健康
背景情况:
- 儿童 (<15岁) 患有利芬素或多药耐药结核病 (RR/MDR-TB) 存在诊断和管理方面的挑战.
- 诊断往往是假设性的,基于暴露和暗示性临床/放射学症状,或治疗失败尽管坚持.
研究的目的:
- 概述儿科RR/MDR-TB的最佳诊断和管理策略.
- 强调个性化,全口腔治疗方案和支持性护理.
主要方法:
- 对诊断方法的审查,包括微生物学确认和推定诊断.
- 影响RR/MDR-TB治疗方案组成和持续时间的因素分析.
- 讨论遵守策略和不良影响管理.
主要成果:
- 个性化,全口服的RR/MDR-TB疗法比儿童的标准化疗法更可取.
- 通过适当的治疗方案,护理人员支持和监测,可以实现高的治疗成功率.
- 对成年RR/MDR-TB病例的密切接触者进行主动查至关重要.
结论:
- 儿童RR/MDR-TB的有效管理取决于早期诊断,个性化全口服治疗和强大的支持性护理.
- 持续努力诊断和治疗未被诊断的儿童RR/MDR-TB至关重要,以减少死亡率.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
相关概念视频
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Treatment Resistant Cancers
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
